Playlist
On September 15, Bassam Ahmed Ali Marzouk, the newly appointed Ambassador Extraordinary and Plenipotentiary of the Kingdom of Bahrain to Turkmenistan (with residence in Ankara), officially commenced his diplomatic mission.
During his visit, he presented his credentials to Chairwoman of the Mejlis of Turkmenistan, Dunyagozel Gulmanova, and held a meeting with Deputy Foreign Minister Serdar Muhammetdurdyyev.
At the Mejlis, Gulmanova conveyed congratulations on behalf of the President of Turkmenistan and wished the ambassador success in strengthening bilateral ties. The ambassador was briefed on Turkmenistan’s domestic and foreign policy priorities and the role of the national parliament.
The sides discussed opportunities for cooperation in various fields — political, economic, cultural, and humanitarian — with special focus on developing interparliamentary dialogue.
At the Foreign Ministry, Ambassador Marzouk praised the hosting of the 3rd UN Conference on Landlocked Developing Countries in the Avaza National Tourist Zone. He emphasized Turkmenistan’s role as a peace-promoting nation in the region and pledged to actively contribute to advancing Bahrain–Turkmenistan relations.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz